Unknown

Dataset Information

0

The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro.


ABSTRACT: Organophosphates (OPs) are potentially able to affect serine proteases by reacting with their active site. The potential effects of OPs on coagulation factors such as thrombin and on coagulation tests have been only partially characterized and potential interactions with OPs antidotes such as oximes and muscarinic blockers have not been addressed. In the current study, we investigated the in vitro interactions between coagulation, thrombin, the OP paraoxon, and its antidotes obidoxime and atropine. The effects of these substances on thrombin activity were measured in a fluorescent substrate and on coagulation by standard tests. Both paraoxon and obidoxime but not atropine significantly inhibited thrombin activity, and prolonged prothrombin time, thrombin time, and partial thromboplastin time. When paraoxon and obidoxime were combined, a significant synergistic effect was found on both thrombin activity and coagulation tests. In conclusion, paraoxon and obidoxime affect thrombin activity and consequently alter the function of the coagulation system. Similar interactions may be clinically relevant for coagulation pathways in the blood and possibly in the brain.

SUBMITTER: Golderman V 

PROVIDER: S-EPMC5045196 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro.

Golderman Valery V   Shavit-Stein Efrat E   Tamarin Ilia I   Rosman Yossi Y   Shrot Shai S   Rosenberg Nurit N   Maggio Nicola N   Chapman Joab J   Eisenkraft Arik A  

PloS one 20160930 9


Organophosphates (OPs) are potentially able to affect serine proteases by reacting with their active site. The potential effects of OPs on coagulation factors such as thrombin and on coagulation tests have been only partially characterized and potential interactions with OPs antidotes such as oximes and muscarinic blockers have not been addressed. In the current study, we investigated the in vitro interactions between coagulation, thrombin, the OP paraoxon, and its antidotes obidoxime and atropi  ...[more]

Similar Datasets

| S-EPMC3636572 | biostudies-literature
| S-EPMC10526462 | biostudies-literature
| S-EPMC4248957 | biostudies-literature
| S-EPMC7385119 | biostudies-literature
| S-EPMC7135739 | biostudies-literature
| S-EPMC4048768 | biostudies-literature
| S-EPMC8778994 | biostudies-literature
| S-EPMC3512051 | biostudies-literature
| S-EPMC5517067 | biostudies-literature